Farther Finance Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-429
Closed -$1.47K – 6285
2026
Q2
$1.47K Buy
429
+132
+44% +$410 ﹤0.01% 5266
2026
Q1
$737 Buy
297
+2
+0.7% +$5 ﹤0.01% 5187
2025
Q4
$826 Sell
295
-4,978
-94% -$17.8K ﹤0.01% 4951
2025
Q3
$25.3K Buy
5,273
+5,111
+3,155% +$32.5K ﹤0.01% 2875
2025
Q2
$1.47K Buy
162
+141
+671% +$1.04K ﹤0.01% 3799
2025
Q1
$190 Sell
21
-1
-5% -$11 ﹤0.01% 3957
2024
Q4
$288 Sell
22
-5
-19% -$67 ﹤0.01% 3565
2024
Q3
$424 Hold
27
– – ﹤0.01% 3463
2024
Q2
$352 Buy
27
+5
+23% +$102 ﹤0.01% 3356
2024
Q1
$605 Sell
22
-1
-4% -$22 ﹤0.01% 2960
2023
Q4
$443 Buy
23
+2
+10% +$36 ﹤0.01% 3007
2023
Q3
$339 Hold
21
– – ﹤0.01% 2359
2023
Q2
$400 Hold
21
– – ﹤0.01% 2214
2023
Q1
$306 Sell
21
-27
-56% -$484 ﹤0.01% 2119
2022
Q4
$937 Buy
+48
New +$936 ﹤0.01% 1670

Other funds holding ACH

Farther Finance Advisors's ACH Position: Q3 2026 in Review

Farther Finance Advisors sold out of Accendra Health (ACH) in Q3 2026, closing a stake of 429 shares — an estimated $1.47K sold.

Farther Finance Advisors first reported a position in ACH in Q4 2022 and held it in 15 quarters. The position peaked at $25.3K in Q3 2025. 1 fund tracked by Wall St. Rank holds ACH as of Q3 2026.

  • Farther Finance Advisors reported no remaining Accendra Health position as of Q3 2026 after selling out during the quarter.
  • Farther Finance Advisors sold 429 Accendra Health shares in Q3 2026, an estimated $1.47K.
  • Farther Finance Advisors first reported a position in Accendra Health in Q4 2022 and held it in 15 quarters.
  • Farther Finance Advisors's Accendra Health position peaked at $25.3K in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Accendra Health as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.